Verve Therapeutics Inc (VERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 32,332 | 11,758 | 1,941 | 0 | 0 |
| Gross Profit | 32,332 | 11,758 | 1,941 | N/A | N/A |
| Operating Expenses | 260,992 | 234,882 | 167,628 | 87,067 | 40,627 |
| Operating Income | -228,660 | -223,124 | -165,687 | -87,067 | -40,627 |
| Other Income | 30,300 | 23,331 | 8,353 | -33,247 | -5,077 |
| Pre-tax Income | -198,360 | -199,793 | -157,334 | -120,314 | -45,704 |
| Income Tax | 349 | 275 | 53 | N/A | N/A |
| Net Income Continuous | -198,709 | -200,068 | -157,387 | -120,314 | -45,704 |
| Net Income | $-198,709 | $-200,068 | $-157,387 | $-120,314 | $-45,704 |
| EPS Basic Total Ops | -2.35 | -3.12 | -2.91 | -4.48 | -20.31 |
| EPS Basic Continuous Ops | -2.35 | -3.12 | -2.91 | -4.48 | -20.31 |
| EPS Diluted Total Ops | -2.35 | -3.12 | -2.91 | -4.48 | -20.31 |
| EPS Diluted Continuous Ops | -2.35 | -3.12 | -2.91 | -4.48 | -20.31 |
| EPS Diluted Before Non-Recurring Items | -2.35 | -3.12 | -2.91 | -4.48 | N/A |
| EBITDA(a) | $-234,312 | $-232,051 | $-163,910 | $-84,024 | $-38,919 |